<DOC>
	<DOCNO>NCT00909012</DOCNO>
	<brief_summary>Patients phenylketonuria ( PKU ) inborn error metabolism amino acid phenylalanine ( Phe ) thus must follow strictly control protein-restricted diet early infancy . This protein-restricted diet devoid natural dietary source n-3 long chain polyunsaturated fatty acid ( LC-PUFA ) , egg , meat , milk fish . Therefore , blood concentration n-3 LC-PUFA , especially docosahexaenoic acid ( DHA ) reduce PKU child compare healthy control . DHA availability consider important optimal neurological function . Previous study show neural function PKU child improve high dose supplementation fish oil provide DHA , show significant improvement visual evoke potential latency fine motor skill coordination , dose response relationship establish far . This multicentric double-blind randomize trial aim determine quantitative DHA requirement optimal neural function PKU child . Patients classical PKU several major treatment center Europe randomize receive 0 15 mg DHA per kg body weight daily duration 6 month . Biochemical ( fatty acid composition plasma phospholipid , lipoprotein metabolism metabolic profile ) , functional testing ( visual evoke potential , fine motor skill , cognitive function marker immune function ) perform baseline 6 month . Intake per kg body weight related outcome parameter thus possible dose response relationship define . The result study expect contribute improvement diet PKU patient , also potential help define quantitative DHA need healthy child . The primary hypothesis supplementation DHA improve visual function child PKU .</brief_summary>
	<brief_title>Quantitative Requirements Docosahexaenoic Acid Neural Function Children With Phenylketonuria</brief_title>
	<detailed_description />
	<mesh_term>Phenylketonurias</mesh_term>
	<criteria>Children classical PKU , diagnose treated newborn period onwards Classical PKU must establish baseline plasma phenylalanine ( PHE ) level &gt; 1200 µmol/L detection underlie mutation Children clinically healthy besides classical PKU Good metabolic control ( minimum 2 Phevalues last 6 month need average Phe value 480 µmol/L last 6 month ) No n3 LCPUFA supplementation least 6 month enrolment Written inform consent parent exist Severe neurological symptom History neurological disease Children unable take DHAcapsules regularly Acute illness , especially infection time clinical examination/testing Children weight/height 97th percentile 3rd percentile Known hypersensitivity fish oil product</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>13 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>phenylketonuria</keyword>
	<keyword>docosahexaenoic acid</keyword>
	<keyword>visually evoke potential</keyword>
	<keyword>choice-reaction time</keyword>
</DOC>